ETOPOSIDE VIATRIS 20 mg/ml

DRUG3 trials

Sponsors

Assistance Publique Hopitaux De Marseille, Association Gercor

Conditions

EpendymomaLocalized digestive Neuroendocrine CarcinomasMedulloblastoma

Phase 1

MEPENDAX: Phase I/II study of axitinib (Inlyta®) and oral metronomic etoposide for pediatric children and AYA with refractory/relapsing medulloblastoma and ependymoma

RecruitingCTIS2023-509585-38-00

Assistance Publique Hopitaux De MarseilleEpendymoma, Medulloblastoma

Start: 2024-11-19Target: 40Updated: 2025-11-07

Phase 2

Phase II study to evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendocrine carcinomas - NEONEC D19-01

WithdrawnCTIS2024-515603-19-00

Association GercorLocalized digestive Neuroendocrine Carcinomas

Target: 78Updated: 2024-08-13

Phase II study to evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendocrine carcinomas - NEONEC D19-01

Not yet recruitingCTIS2024-515603-19-01

Association GercorLocalized digestive Neuroendocrine Carcinomas

Target: 78Updated: 2025-10-14